Facilitating Novel Clinical Insights through the Adoption of Spatial Omics & Digital Pathology in Translational Workflows
- Evaluating emerging technologies to demonstrate their clinical utility
- Charting a clear regulatory course for bringing spatial omics and digital pathology into clinical research
- Presenting clinical evidence that showcases the added value of spatial biology and digital pathology in across therapeutic pipelines